2017
DOI: 10.5546/aap.2017.e34
|View full text |Cite
|
Sign up to set email alerts
|

Estudio clínico y molecular en una familia con displasia ectodérmica hipohidrótica autosómica dominante

Abstract: Presentación de casos clínicos RESUMENLa displasia ectodérmica hipohidrótica (DEH) es una entidad infrecuente caracterizada por deficiencia en el desarrollo de estructuras derivadas del ectodermo y es causada por mutaciones en los genes EDA, EDAR o EDARADD, que pueden exhibir hallazgos clínicos similares, debido a una vía de señalización común. Las mutaciones en el gen EDA causan la DEH ligada al X, que es la forma más frecuente. Por su parte, las mutaciones en los genes EDAR y EDARADD causan la DEH con patrón… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…In CTLN1, hepatomegaly seems to occur mostly during acute episodes (Faghfoury et al 2011). ALF has been reported in children and adults, including as the presenting feature, and is recurrent in a number of patients (Ito et al 2004;Salek et al 2010;de Groot et al 2010;Bindi and Eiroa 2017), pregnancy being a common trigger (Ito et al 2004;Salek et al 2010;Sinclair et al 2014). Liver function mostly improved with treatment of citrullinemia; however, one patient did not recover, and persistent liver failure led to death in a few months (Ito et al 2004).…”
Section: Argininosuccinate Synthetase Deficiency: Citrullinemia Type mentioning
confidence: 99%
“…In CTLN1, hepatomegaly seems to occur mostly during acute episodes (Faghfoury et al 2011). ALF has been reported in children and adults, including as the presenting feature, and is recurrent in a number of patients (Ito et al 2004;Salek et al 2010;de Groot et al 2010;Bindi and Eiroa 2017), pregnancy being a common trigger (Ito et al 2004;Salek et al 2010;Sinclair et al 2014). Liver function mostly improved with treatment of citrullinemia; however, one patient did not recover, and persistent liver failure led to death in a few months (Ito et al 2004).…”
Section: Argininosuccinate Synthetase Deficiency: Citrullinemia Type mentioning
confidence: 99%
“…Currently, the incidence of UCD in Latin America is not known. There are few publications describing patients of Argentina, and they lack accurate information on the incidence of these diseases [6][7][8][9]. However, according to the European guidelines for the diagnosis and treatment of urea cycle disorders, the incidence is estimated to be 1: 8,000-1: 44,000 live births [10].…”
Section: Introductionmentioning
confidence: 99%